LIPOSKILL PLUS is a technology that allows breast reshaping and augmentation based on the use of adipose tissue stem cells (ADSCs, Adipose-Derived Stem Cells). Using autologous stem cells (i.e., taken from the patient who will undergo the treatment) avoids the use of any substance foreign to the organism, including the classic artificial implants.
The use of autologous cells reduces or even excludes the risk of complications such as infections or capsular contractures. For this reason, many women prefer the ADSC-based approach to traditional breast augmentation procedures.
The procedure involves taking a sample of accumulated fat at the level of one of the patient’s so-called “critical points”. Stem cells are extracted from this fat to be used to reshape the breasts and obtain an increase in volume. It is also possible to correct any asymmetries or defects caused by previous plastic surgery.